NIH-National Institute of General Medical Sciences

Michael McLeod

Postdoctoral Researcher, CMLD
Primary office:
785-864-8153
Structural Biology Center, room #2071


Dr. Michael McLeod was born in Reading, UK in 1983. He received a first class MSci degree in chemistry from the University of Nottingham, UK. Remaining at the same institution, Michael obtained a PhD under the supervision of Professor Barry Lygo. His postgraduate research included the development of methodology to allow highly enantioselective Michael additions of glycine imines and its application to the total synthesis of biologically active alkaloids. He then took up a postdoctoral position with Professor Margaret Brimble at the University of Auckland, New Zealand, where he completed an asymmetric total synthesis of the natural product berkelic acid. He is currently a postdoctoral researcher with Professor Jeffrey Aubé at the University of Kansas, US, where his research involves the preparation of natural product-inspired libraries for biological screening​.


48 nationally ranked graduate programs.
—U.S. News & World Report
Pharmacy school No. 2 nationally for NIH funding
Hall Center receives 3rd NEH challenge grant to support humanities research collaboration
Regional leader in technology commercialization
12 graduate programs rank in top 10 nationally among public universities.
—U.S. News & World Report
Driving discovery, innovation, entrepreneurship
Home to 15 major research centers & state surveys
1st in nation for its special education master’s and doctorate programs.
—U.S. News & World Report
1st in nation for its city management and urban policy master’s program.
—U.S. News & World Report
One of 34 U.S. public institutions in the prestigious Association of American Universities
KU Today